Log in

Bayesian Forecasting of Serum Gentamicin Concentrations in Intensive Care Patients

  • Original Research Article
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Summary

This study retrospectively evaluated the predictive performance of a 1-compartment Bayesian forecasting program in adult intensive care unit (ICU) patients with stable renal function. A comparison was made of the reliability of 3 sets of population-based parameter estimates and 2 serum concentration monitoring strategies. A larger mean error for prediction of peak gentamicin concentrations was seen with literature-derived parameters than when ICU population-based parameter estimates were used. Bias and precision improved when non-steady-state peak and trough concentrations were used to predict those at steady-state; the addition of steady-state values did not provide additional information for predictions once non-steady-state feedback concentrations were incorporated. The addition of 4 serial gentamicin concentrations obtained at both non-steady-state and steady-state did not noticeably improve the predictive performance.

The results demonstrate that initial ICU pharmacokinetic parameter estimates for a 1-compartment Bayesian model provide accurate prediction of steady-state gentamicin concentrations. Prediction bias and precision showed the greatest improvement when non-steady-state gentamicin concentrations were used to determine individualised pharmacokinetic parameters.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bodenham A, Shelly MP, Park GR. The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients. Clinical Pharmacokinetics 14: 347–373, 1988

    Article  PubMed  CAS  Google Scholar 

  • Burton ME, Chow MSS, Platt DR, Day RB, Brater DC, et al. Accuracy of Bayesian and Sawchuk-Zaske dosing methods for gentamicin. Clinical Pharmacy 5: 143–149, 1986

    PubMed  CAS  Google Scholar 

  • Chelluri L, Jastremski MS. Inadequacy of standard aminoglycoside loading doses in acutely ill patients. Critical Care Medicine 15: 1143–1145, 1987

    Article  PubMed  CAS  Google Scholar 

  • Chelluri L, Warren J, Jastremski MS. Pharmacokinetics of a 3 mg/kg body weight loading dose of gentamicin or tobramycin in critically ill patients. Chest 95: 1295–1297, 1989

    Article  PubMed  CAS  Google Scholar 

  • Cockcroft DW, Gault MH. Prediction of Creatinine clearance from serum Creatinine. Nephron 16: 31–41, 1976

    Article  PubMed  CAS  Google Scholar 

  • Dasla JF. Drug use in a surgical intensive care unit. Drug Intelligence and Clinical Pharmacy 20: 752–756, 1986

    Google Scholar 

  • Datas JF, Armstrong DK. Variability in aminoglycoside pharmacokinetics in critically ill surgical patients. Critical Care Medicine 16: 327–330, 1988

    Article  Google Scholar 

  • Hassan E, Ober JD. Predicted and measured aminoglycoside pharmacokinetic parameters in critically ill patients. Antimicrobial Agents and Chemotherapy 31: 1855–1858, 1987

    Article  PubMed  CAS  Google Scholar 

  • Kreger BE, Craven DE, McCabe WR. Gram-negative bacteremia: re-evaluation of clinical features and treatment in 612 patients. American Journal of Medicine 68: 344–355, 1980

    Article  PubMed  CAS  Google Scholar 

  • Mann HJ, Fuhs DW, Awang R, Ndemo FA, Cerra FB. Altered aminoglycoside pharmacokinetics in critically ill patients with sepsis. Clinical Pharmacy 6: 148–153, 1987

    PubMed  CAS  Google Scholar 

  • Moore RD, Smith CR, Lielman PS. The association of aminoglycoside plasma levels with mortality in patients with Gramnegative bacteremia. Journal of Infectious Disease 149: 443–448, 1984

    Article  CAS  Google Scholar 

  • Niemiec PW, Allo MD, Miller CF. Effect of altered volume of distribution on aminoglcoside levels in patients in surgical intensive care. Archives of Surgery 122: 207–212, 1987

    Article  PubMed  Google Scholar 

  • Noone P, Parsons TMC, Pattison JR, Slack RCB, Garfield-Davies D, et al. Experience in monitoring gentamicin therapy during serious Gram-negative sepsis. British Medical Journal 1: 477–481, 1974

    Article  PubMed  CAS  Google Scholar 

  • Pryka RD, Rodvold KA, Garrison M, Rotschafer JC. Individualizing vancomycin dosage regimens: one- vs two-compartment Bayesian models. Therapeutic Drug Monitoring 11: 450–454, 1989

    PubMed  CAS  Google Scholar 

  • Rodvold KA, Blum RA. Predictive performance of Sawchuk-Zaske and Bayesian dosing methods for tobramycin. Journal of Clinical Pharmacology 27: 419–427, 1987

    PubMed  CAS  Google Scholar 

  • Rodvold KA, Pryka RD, Garrison M, Rotschafer JC. Evaluation of a two compartment Bayesian forecasting program for predicting vancomycin concentrations. Therapeutic Drug Monitoring 11: 269–275, 1989

    Article  PubMed  CAS  Google Scholar 

  • Rodvold KA, Zokufa H, Rotschafer JC. Aminoglycoside pharmacokinetic monitoring: an integral part of patient care? Clinical Pharmacy 7: 608–613, 1988

    PubMed  CAS  Google Scholar 

  • Sawchuk RJ, Zaske DE. Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients. Journal of Pharmacokinetics and Biopharmaceutics 4: 183–195, 1976

    PubMed  CAS  Google Scholar 

  • Sheiner LB, Beal SL, Rosenberg B, Marathe VV. Forecasting individual pharmacokinetics. Clinical Pharmacology and Therapeutics 26: 294–305, 1979

    PubMed  CAS  Google Scholar 

  • Sheiner LB, Beal SL. Some suggestions for measuring predictive performance. Journal of Pharmacokinetics and Biopharmaceutics 9: 503–512, 1981

    PubMed  CAS  Google Scholar 

  • Schumacher GE, Barr JT. Bayesian approaches in pharmacokinetic decision making. Clinical Pharmacy 3: 525–530, 1984

    PubMed  CAS  Google Scholar 

  • Sultan E, Richard C, Pezzano M, Auzepy P, Singlas E. Pharmacokinetics of Pefloxacin and amikacin administered simultaneously to intensive care patients. European Journal of Clinical Pharmacology 34: 637–643, 1988

    Article  PubMed  CAS  Google Scholar 

  • Summer WR, Michael JR, Lipsky JJ. Initial aminoglycoside levels in the critically ill. Critical Care Medicine 11: 948–950, 1983

    Article  PubMed  CAS  Google Scholar 

  • Townsend PL, Fink MP, Stein KL, Murphy SG. Aminoglycoside pharmacokinetics: dosage requirements and nephrotoxicity in trauma patients. Critical Care Medicine 17: 154–157, 1989

    Article  PubMed  CAS  Google Scholar 

  • Vožeh S, Uematsu T, Hauf GF, Follath F. Performance of Bayesian feedback to forecast lidocaine serum concentration: evaluation of the prediction error and the perdition interval. Journal of Pharmacokinetics and Biopharmaceutics 13: 203–211, 1985

    PubMed  Google Scholar 

  • Zaske DE. Aminoglycosides. In Evans et al. (Eds) Applied Pharmacokinetic Principles of Therapeutic Drug Monitoring. 2nd ed., pp. 331–381, Applied Therapeutics. Spokane. Washington, 1986

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rodvold, K.A., Pryka, R.D., Kuehl, P.G. et al. Bayesian Forecasting of Serum Gentamicin Concentrations in Intensive Care Patients. Clin Pharmacokinet 18, 409–418 (1990). https://doi.org/10.2165/00003088-199018050-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-199018050-00005

Keywords

Navigation